Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype
- 18 October 2007
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 14 (12), 1329-1333
- https://doi.org/10.1111/j.1468-1331.2007.01972.x
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative syndrome with familial and sporadic forms. Most ALS-associated mutations are found in the superoxide dismutase 1 (SOD1) gene. We conducted a study including 60 sporadic and 19 familial ALS patients, 206 reference patients with other neurological disorders and 40 age- and sex-matched healthy controls to test the hypothesis that cerebrospinal fluid (CSF) levels of neurofilament light (NF-L) protein, a marker of axonal degeneration, might provide diagnostic and prognostic information on the disease. All ALS patients were screened for SOD1 mutations. Ten of the familial and five of the sporadic cases carried SOD1 mutations. NF-L concentration [median (range)] was strongly elevated in ALS [2110 (255–10 800) ng/l] compared with reference patients and healthy controls [277 (P < 0.001] and correlated inversely with disease duration (Spearman R = −0.518, P = 0.001). NF-L levels were lower in SOD1 mutation-associated ALS compared with SOD1 wild-type (wt) ALS (P = 0.03). In conclusion, CSF NF-L levels may provide both diagnostic and prognostic information, particularly in SOD1 wt ALS.Keywords
This publication has 22 references indexed in Scilit:
- Axonal damage markers in cerebrospinal fluid are increased in ALSNeurology, 2006
- Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALSNeurology, 2006
- The Inconsistency of “Optimal” Cutpoints Obtained using Two Criteria based on the Receiver Operating Characteristic CurveAmerican Journal of Epidemiology, 2006
- Survival of Patients with Amyotrophic Lateral Sclerosis in a Population-Based RegistryNeuroepidemiology, 2005
- Mutant Copper-Zinc Superoxide Dismutase Binds to and Destabilizes Human Low Molecular Weight Neurofilament mRNAJournal of Biological Chemistry, 2005
- Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serumNeuroscience Letters, 2003
- Neurofilaments and neurological diseaseBioEssays, 2003
- Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSFJournal of Neurochemistry, 1996
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisThe New England Journal of Medicine, 1994
- Neurofilament phosphorylation: a new look at regulation and functionTrends in Neurosciences, 1991